









Markets
/
Stocks
/
nasdaq-imdx
/

Insight Molecular Diagnostics Ord Shs

IMDX

5.020USD

-0.195-3.74%

Close 12/15, 16:00（ET）Quotes delayed by 15 min

143.70MMarket Cap

LossP/E TTM



Insight Molecular Diagnostics Ord Shs

5.020

-0.195-3.74%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of Insight Molecular Diagnostics Ord Shs here for insights into the performance and operational efficiency of Insight Molecular Diagnostics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total revenue

--260.00K

Revenue

--260.00K

Cost of revenue

--121.00K

Operating expenses

--7.93M

R&D expenses

--3.55M

Depreciation, depletion, and amortization

--584.00K

Operating profit

---7.67M

Net non-operating interest income (expenses)

Non-operating interest expense

--29.00K

Special income (expenses)

---3.38M

Other non-operating income (expenses)

--223.00K

Income before tax

---10.85M

Income tax

--0.00

Income after tax

---10.85M

Net income from continuous operations

---10.85M

Net income attributable to controlling interests

---10.85M

Net income attributable to common shareholders

---10.85M

Basic earnings per share

---0.34

Diluted earnings per share

---0.34

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

